In vivo toxicity of quantum dots: no cause for concern?
Semiconductor nanocrystals, also known as quantum dots (QDs), possess unique optical properties that make them useful as fluorescent probes or traceable nanocarriers for in vivo applications ranging from imaging to theranostics. The surfaces of QDs can be conjugated with biomolecules to enable...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Journal Article |
| Language: | English |
| Published: |
2013
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/10356/102119 http://hdl.handle.net/10220/18145 |
| _version_ | 1811681084805480448 |
|---|---|
| author | Swihart, Mark T. Yong, Ken-Tye |
| author2 | School of Electrical and Electronic Engineering |
| author_facet | School of Electrical and Electronic Engineering Swihart, Mark T. Yong, Ken-Tye |
| author_sort | Swihart, Mark T. |
| collection | NTU |
| description | Semiconductor nanocrystals, also known as
quantum dots (QDs), possess unique optical
properties that make them useful as fluorescent
probes or traceable nanocarriers for in vivo applications ranging from imaging to theranostics.
The surfaces of QDs can be conjugated with
biomolecules to enable in vivo targeted imaging
and drug delivery. These unique capabilities
and qualities of QDs have made them a powerful
platform that can help to reveal important biological insights. Ultimately, they may also provide unique benefits in clinical diagnostic and therapeutic applications. However, progress toward clinical applications has been delayed by concerns about the potential toxicity of QDs. Much of the QDs community has been hesitant to work toward clinical applications, based on reports demonstrating release of toxic heavy metal ions from degradation of QDs in cell culture studies. In addition, photoexcited QDs have been
shown to generate reactive oxygen species that
are highly toxic to cells. On the other hand,
in small animal studies, bioconjugated QDs did
not have any observable ill effects at concentrations appropriate for in vivo imaging applications. Thus, conclusions drawn from in vitro and in vivo studies remain somewhat contradictory and do not yet provide a sound basis for confident prediction of in vivo toxicity in humans. |
| first_indexed | 2024-10-01T03:35:20Z |
| format | Journal Article |
| id | ntu-10356/102119 |
| institution | Nanyang Technological University |
| language | English |
| last_indexed | 2024-10-01T03:35:20Z |
| publishDate | 2013 |
| record_format | dspace |
| spelling | ntu-10356/1021192020-03-07T13:57:24Z In vivo toxicity of quantum dots: no cause for concern? Swihart, Mark T. Yong, Ken-Tye School of Electrical and Electronic Engineering DRNTU::Science::Medicine Semiconductor nanocrystals, also known as quantum dots (QDs), possess unique optical properties that make them useful as fluorescent probes or traceable nanocarriers for in vivo applications ranging from imaging to theranostics. The surfaces of QDs can be conjugated with biomolecules to enable in vivo targeted imaging and drug delivery. These unique capabilities and qualities of QDs have made them a powerful platform that can help to reveal important biological insights. Ultimately, they may also provide unique benefits in clinical diagnostic and therapeutic applications. However, progress toward clinical applications has been delayed by concerns about the potential toxicity of QDs. Much of the QDs community has been hesitant to work toward clinical applications, based on reports demonstrating release of toxic heavy metal ions from degradation of QDs in cell culture studies. In addition, photoexcited QDs have been shown to generate reactive oxygen species that are highly toxic to cells. On the other hand, in small animal studies, bioconjugated QDs did not have any observable ill effects at concentrations appropriate for in vivo imaging applications. Thus, conclusions drawn from in vitro and in vivo studies remain somewhat contradictory and do not yet provide a sound basis for confident prediction of in vivo toxicity in humans. 2013-12-06T07:05:48Z 2019-12-06T20:50:01Z 2013-12-06T07:05:48Z 2019-12-06T20:50:01Z 2012 2012 Journal Article Yong, K.-T., & Swihart, M. T. (2012). In vivo toxicity of quantum dots: no cause for concern?. Nanomedicine, 7(11), 1641-1643. https://hdl.handle.net/10356/102119 http://hdl.handle.net/10220/18145 10.2217/nnm.12.152 en Nanomedicine |
| spellingShingle | DRNTU::Science::Medicine Swihart, Mark T. Yong, Ken-Tye In vivo toxicity of quantum dots: no cause for concern? |
| title | In vivo toxicity of quantum dots: no cause for concern? |
| title_full | In vivo toxicity of quantum dots: no cause for concern? |
| title_fullStr | In vivo toxicity of quantum dots: no cause for concern? |
| title_full_unstemmed | In vivo toxicity of quantum dots: no cause for concern? |
| title_short | In vivo toxicity of quantum dots: no cause for concern? |
| title_sort | in vivo toxicity of quantum dots no cause for concern |
| topic | DRNTU::Science::Medicine |
| url | https://hdl.handle.net/10356/102119 http://hdl.handle.net/10220/18145 |
| work_keys_str_mv | AT swihartmarkt invivotoxicityofquantumdotsnocauseforconcern AT yongkentye invivotoxicityofquantumdotsnocauseforconcern |